GlaxoSmithKline bets on 'electroceuticals'GlaxoSmithKline, Britain's biggest drugmaker, is placing a small but important bet on a new way of treating diseases by targeting electrical signals in the body. The company said on Wednesda More… |
GlaxoSmithKline wins US approval for new vaccineUS health regulators have approved a new four-strain seasonal influenza vaccine made by GlaxoSmithKline, the company said. The US Food and Drug Administration has approved Fluarix Quadrivalent to immunise children age 3 and older More… |
Malaria vaccine disappoints in trialA GlaxoSmithKline experimental malaria vaccine touted as a new weapon in the fight to eradicate the disease proved only 30 percent effective when given to babies as part Africa's largest ever clinical trial. &n More… |
GSK extends $2.6bn offer to key partnerGlaxoSmithKline has extended its $2.6 billion offer to buy long-time partner Human Genome Sciences until the end of June as it battles the US biotech company's reluctant management. The price remains unchanged at $13 a share under the  More… |
Sanofi strong in emerging markets as rivals flagFrench drugmaker Sanofi posted better-than-expected quarterly results, bolstered by strong emerging markets, breaking with a trend of earnings misses by European rivals AstraZeneca and GlaxoSmithkline. Sanofi performed strongly in Chi More… |
GlaxoSmithKline settles US drug rows for $3bnGlaxoSmithKline has agreed in principle to settle its most significant disputes with the US government over the way it marketed and developed its drugs, at a cost of $3 billion, which is covered by existing provisions. The settlement, over More… |
Copy of top GSK lung drug wins approvalSwedish authorities have approved a copycat version of GlaxoSmithKline's top-selling lung drug Advair in a move that also clears the way for its launch in several other European markets, including Germany and Italy. The green light for th More… |
Sensodyne toothpaste launched in LebanonGlaxoSmithKline (GSK) has announced the Lebanon launch of its Sensodyne Repair and Protect, a toothpaste that helps continuously repair sensitive teeth. GSK revealed that this is the first daily fluoride toothpaste to contain Novamin, an a More… |
GSK cream ‘effective’ for diaper rashA new cream from GlaxoSmithKline (GSK) is proving to be among the more popular choices for parents seeking a safe and effective product for treating diaper rashes. Drapolene is a specially formulated cream to soothe diaper rashes as well a More… |
GSK launches toothpaste campaignGlaxoSmithKline (GSK) has launched of a region-wide campaign to demonstrate the efficacy of its toothpaste that is formulated to offer sensitivity relief within 60 seconds to people suffering from sensitive teeth. Titled Sensodyne Rapid Ac More… |








